205 related articles for article (PubMed ID: 11043499)
1. Cyclosporine-A plus steroids versus steroids alone in the 12-month treatment of systemic lupus erythematosus.
Dammacco F; Della Casa Alberighi O; Ferraccioli G; Racanelli V; Casatta L; Bartoli E
Int J Clin Lab Res; 2000; 30(2):67-73. PubMed ID: 11043499
[TBL] [Abstract][Full Text] [Related]
2. Repeated pulses of methyl-prednisolone with reduced doses of prednisone improve the outcome of class III, IV and V lupus nephritis: An observational comparative study of the Lupus-Cruces and lupus-Bordeaux cohorts.
Ruiz-Irastorza G; Ugarte A; Saint-Pastou Terrier C; Lazaro E; Iza A; Couzi L; Saenz R; Richez C; Porta S; Blanco P
Autoimmun Rev; 2017 Aug; 16(8):826-832. PubMed ID: 28564619
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group.
Cattran DC; Appel GB; Hebert LA; Hunsicker LG; Pohl MA; Hoy WE; Maxwell DR; Kunis CL
Kidney Int; 1999 Dec; 56(6):2220-6. PubMed ID: 10594798
[TBL] [Abstract][Full Text] [Related]
4. Corticosteroid dose and the risk of opportunistic infection in a national systemic lupus erythematosus cohort.
Yang SC; Lai YY; Huang MC; Tsai CS; Wang JL
Lupus; 2018 Oct; 27(11):1819-1827. PubMed ID: 30103646
[TBL] [Abstract][Full Text] [Related]
5. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
Moroni G; Doria A; Mosca M; Alberighi OD; Ferraccioli G; Todesco S; Manno C; Altieri P; Ferrara R; Greco S; Ponticelli C
Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
[TBL] [Abstract][Full Text] [Related]
6. Infections in newly diagnosed Spanish patients with systemic lupus erythematosus: data from the RELES cohort.
González-Echavarri C; Capdevila O; Espinosa G; Suárez S; Marín-Ballvé A; González-León R; Rodríguez-Carballeira M; Fonseca-Aizpuru E; Pinilla B; Pallarés L; Ruiz-Irastorza G;
Lupus; 2018 Dec; 27(14):2253-2261. PubMed ID: 30451641
[TBL] [Abstract][Full Text] [Related]
7. The administration of low doses of rituximab followed by hydroxychloroquine, prednisone and low doses of mycophenolate mofetil is an effective therapy in Latin American patients with active systemic lupus erythematosus.
Galarza-Maldonado C; Kourilovitch MR; Molineros JE; Cardiel MH; Zurita L; Soroka NF; Yagur VY; Doukh N; Cervera R
Autoimmun Rev; 2010 Dec; 10(2):108-11. PubMed ID: 20804861
[TBL] [Abstract][Full Text] [Related]
8. Combined mepacrine-hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity.
Ugarte A; Porta S; Ríos R; Martinez-Zapico A; Ortego-Centeno N; Agesta N; Ruiz-Irastorza G
Lupus; 2018 Sep; 27(10):1718-1722. PubMed ID: 29635998
[TBL] [Abstract][Full Text] [Related]
9. [Methylprednisolone and cyclophosphamide pulse therapy of severe systemic lupus erythematosus in children].
Hu J; Li CW; Zhang X; Pi SH; Zhao JS; Chen XY; Liu Y
Zhonghua Er Ke Za Zhi; 2003 Jun; 41(6):430-4. PubMed ID: 14748998
[TBL] [Abstract][Full Text] [Related]
10. Mizoribine for the treatment of lupus nephritis in children and adolescents.
Tanaka H; Tsugawa K; Tsuruga K; Suzuki K; Nakahata T; Ito E; Waga S
Clin Nephrol; 2004 Dec; 62(6):412-7. PubMed ID: 15630899
[TBL] [Abstract][Full Text] [Related]
11. Azathioprine plus prednisone compared with prednisone alone in the treatment of systemic lupus erythematosus. Report of a prospective controlled trial in 24 patients.
Hahn BH; Kantor OS; Osterland CK
Ann Intern Med; 1975 Nov; 83(5):597-605. PubMed ID: 1106277
[TBL] [Abstract][Full Text] [Related]
12. The BILAG multi-centre open randomized controlled trial comparing ciclosporin vs azathioprine in patients with severe SLE.
Griffiths B; Emery P; Ryan V; Isenberg D; Akil M; Thompson R; Maddison P; Griffiths ID; Lorenzi A; Miles S; Situnayake D; Teh LS; Plant M; Hallengren C; Nived O; Sturfelt G; Chakravarty K; Tait T; Gordon C
Rheumatology (Oxford); 2010 Apr; 49(4):723-32. PubMed ID: 20081225
[TBL] [Abstract][Full Text] [Related]
13. The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus: findings of a prospective, randomized, double-blind, placebo-controlled trial.
Tseng CE; Buyon JP; Kim M; Belmont HM; Mackay M; Diamond B; Marder G; Rosenthal P; Haines K; Ilie V; Abramson SB
Arthritis Rheum; 2006 Nov; 54(11):3623-32. PubMed ID: 17075807
[TBL] [Abstract][Full Text] [Related]
14. Enteric-coated mycophenolate sodium versus azathioprine in patients with active systemic lupus erythematosus: a randomised clinical trial.
Ordi-Ros J; Sáez-Comet L; Pérez-Conesa M; Vidal X; Mitjavila F; Castro Salomó A; Cuquet Pedragosa J; Ortiz-Santamaria V; Mauri Plana M; Cortés-Hernández J
Ann Rheum Dis; 2017 Sep; 76(9):1575-1582. PubMed ID: 28450313
[TBL] [Abstract][Full Text] [Related]
15. Severe multiorganic flare of systemic lupus erythematosus successfully treated with rituximab and cyclophosphamide avoiding high doses of prednisone.
Gonzalez-Echavarri C; Pernas B; Ugarte A; Ruiz-Irastorza G
Lupus; 2014 Mar; 23(3):323-6. PubMed ID: 24531426
[TBL] [Abstract][Full Text] [Related]
16. Remission and low disease activity state prevent hospitalizations in systemic lupus erythematosus patients.
Reátegui-Sokolova C; Rodríguez-Bellido Z; Gamboa-Cárdenas RV; Medina M; Zevallos F; Pimentel-Quiroz VR; Elera-Fitzcarrald C; Cucho-Venegas M; Pastor-Asurza CA; Perich-Campos R; Alarcón GS; Ugarte-Gil MF
Lupus; 2019 Oct; 28(11):1344-1349. PubMed ID: 31551028
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes with multi-targeted immunosuppressive protocol in children with severe proliferative lupus nephritis.
Aragon E; Resontoc LP; Chan YH; Lau YW; Tan PH; Loh HL; Ng KH; Yap HK
Lupus; 2016 Apr; 25(4):399-406. PubMed ID: 26537422
[TBL] [Abstract][Full Text] [Related]
18. Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study.
Fanouriakis A; Adamichou C; Koutsoviti S; Panopoulos S; Staveri C; Klagou A; Tsalapaki C; Pantazi L; Konsta S; Mavragani CP; Dimopoulou D; Ntali S; Katsikas G; Boki KA; Vassilopoulos D; Konstantopoulou P; Liossis SN; Elezoglou A; Tektonidou M; Sidiropoulos P; Erden A; Sfikakis PP; Bertsias G; Boumpas DT
Semin Arthritis Rheum; 2018 Dec; 48(3):467-474. PubMed ID: 29555348
[TBL] [Abstract][Full Text] [Related]
19. Management of non-renal non-neurologic persistent lupus activity in real world patients from Argentina.
Scolnik M; Scaglioni V; Pons-Estel GJ; Soriano ER
Lupus; 2019 Aug; 28(9):1167-1173. PubMed ID: 31299882
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporine A in the long-term management of systemic lupus erythematosus.
Germano V; Picchianti Diamanti A; Ferlito C; Podestà E; Salemi S; Migliore A; D' Amelio R; Laganà B
J Biol Regul Homeost Agents; 2011; 25(3):397-403. PubMed ID: 22023764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
